Current NDC auxiliary source row compounder:3944

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 85974-210
Product Ndc: 85974-210
Product Ndc Digits: 85974210
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: MaxMist 2%
Proprietary Name Suffix: [empty]
Nonproprietary Name: tetracaine hcl 2%, bupivacaine hcl 0.5%, phenylephrine hcl 1% spray
Dosage Form Name: SPRAY
Route Name: NASAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Bennett Pharmaceuticals of America, LLC
Establishment Name: Bennett Pharmaceuticals of America, LLC
Establishment Fei: [empty]
Substance Name: TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredients Info: 20 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL
History Active Ingredients Raw: TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
History Active Ingredients Info Raw: 20 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL
History Dosage Raw: SPRAY
Dea Schedule: [empty]
Package Ndc Raw: 85974-210-13
Package Ndc: 85974-210-13
Package Ndc Digits: 8597421013
Package Ndc11: 85974021013
Package Description: 4 mL in 1 BOTTLE, SPRAY (85974-210-13)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3944
Source Row Number: 3944
Source Row Hash: 184fe8c43527602f8a5baa30642d83b1594ad32b854939445a6691800437b7e9
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "NASAL",
    "PRODUCTNDC": "85974-210",
    "DEASCHEDULE": "",
    "LABELERNAME": "Bennett Pharmaceuticals of America, LLC",
    "SUBSTANCENAME": "TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "SPRAY",
    "NDCPACKAGECODE": "85974-210-13",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "MaxMist 2%",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "tetracaine hcl 2%, bupivacaine hcl 0.5%, phenylephrine hcl 1% spray",
    "PACKAGEDESCRIPTION": "4 mL in 1 BOTTLE, SPRAY (85974-210-13) ",
    "ACTIVEINGREDIENTSINFO": "20 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3944
Source Row Number: 3944
Status Scope: package
Lookup Ndc: 85974-210-13
Lookup Ndc Digits: 8597421013
Product Ndc: 85974-210
Product Ndc Digits: 85974210
Package Ndc: 85974-210-13
Package Ndc Digits: 8597421013
Package Ndc11: 85974021013
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 184fe8c43527602f8a5baa30642d83b1594ad32b854939445a6691800437b7e9
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27